Respreeza 1,000 mg powder and solvent for solution for infusion.
- Licence status
- Active substances
- Human alpha1-proteinase inhibitor
- Dosage Form
- Powder and solvent for solution for injection
- Licence number
- EU/1/15/1006/001
- Licence holder
- CSL Behring GmbH
Product documents
Licence information
- ATC code
- B02AB Proteinase inhibitors, B02AB02 alfa1 antitrypsin
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued